Circa Group AS
Circa Group AS engages in the production and sale of biochemicals in Australia, France, the United Kingdom, Belgium, and Norway. The company extracts value from non-food waste biomass to produce bio-based chemicals through its Furacell production process. Its products include Cyrene, a polar aprotic solvent; and Levoglucosenone derivatives. The company's products are used in pharmaceuticals, agro… Read more
Circa Group AS - Asset Resilience Ratio
Circa Group AS (CIRCA) has an Asset Resilience Ratio of 41.59% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how Circa Group AS's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Circa Group AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr14.96 Million | 41.59% |
| Short-term Investments | Nkr0.00 | 0% |
| Total Liquid Assets | Nkr14.96 Million | 41.59% |
Asset Resilience Insights
- Very High Liquidity: Circa Group AS maintains exceptional liquid asset reserves at 41.59% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Circa Group AS Industry Peers by Asset Resilience Ratio
Compare Circa Group AS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Circa Group AS (2021–2023)
The table below shows the annual Asset Resilience Ratio data for Circa Group AS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-06-30 | 80.74% | Nkr34.77 Million | Nkr43.06 Million | -13.24pp |
| 2022-06-30 | 93.98% | Nkr44.42 Million | Nkr47.27 Million | +14.34pp |
| 2021-06-30 | 79.64% | Nkr5.21 Million | Nkr6.54 Million | -- |